TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan gets FDA approval of blood pressure drug

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Daily Photo Galleries

Tuesday, Nov. 13, 2012, 10:34 a.m.
 

Mylan Inc. said on Tuesday that it gained Food and Drug Administration approval for a generic blood pressure drug.

Cecil-based Mylan said it has started shipping Sildenafil Citrate tablets, the generic version of Pfizer Inc.'s Revatio.

Revatio had U.S. sales of $338.7 million in the 12 months ended Sept. 30.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or anixon@tribweb.com.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Stories

  1. Starkey: Rutherford hits jackpot with Kessel
  2. Rossi: Wild Wednesday proves Steelers rule
  3. 2B Walker, Pirates smash through Tigers pitching in road victory
  4. Penguins get their man in making trade with Toronto for Kessel
  5. Penguins notebook: Rutherford proves savvy in deal
  6. Pirates notebook: Cole cool about hostile comment
  7. Judge revokes bail for Plum High School teacher
  8. New Kensington residents rally in support of 82-year-old robbery victim
  9. Pittsburgh a big draw for tourists on July 4th weekend
  10. Steelers submit application to play host to Super Bowl in 2023
  11. Ligonier Township officer’s widow to file civil suit